EGF Theramed Health Aktie

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, EGF Theramed Health Aktie had revenue of €0 and net profit of -€69.14K

(EUR)	March 2026	YoY
Revenue	0	-
Gross profit	0	-
Net profit	-69.14K	-
EBITDA	-51.78K	-

Fundamentals

Metric	Value
Market capitalization	€228.36K
Number of shares	11.62M
52-week high/low	€0.16 - €0.0197
Dividends	No
Beta	0.30
P/E ratio	-0.15
PEG ratio	0.00
P/B ratio	-0.08
P/S ratio	0.00

Company profile

EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.